Tag Archives: Nautilus

BIO Coalition Submits Patent Reform Letter to Congress

medical_research

BIO, alongside a coalition of patent holders and inventors, submitted a letter to the chairmen and ranking members of the House and Senate Judiciary Committees on December 10 regarding potential changes to the patent system. The coalition thanked members of the committee for their work to develop reforms which would prevent harmful patent enforcement practices, and once again reiterated their opposition to any legislation that would weaken the overall patent system. They also asked that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , ,

Patent Cases Down by 40% in 2014

Patent-Case-Filings-by-Month-2011-20141

The number of new patent cases filed in federal court has dropped by an astonishing 40 percent as compared to this time last year. This trend has some questioning whether Congressional patent reform is even necessary. Some legal experts are attributing this drop to the fallout from the U.S. Supreme Court’s recent Alice vs. CLS Bank decision. In June, SCOTUS ruled in the case of Alice that certain subject matter which had been patentable (a computer-implemented Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , ,

Supreme Court Enunciates New Indefiniteness Standard

Noonan

The Supreme Court has once again reversed a decision by the Federal Circuit, in this case involving the proper standard for finding claims indefinite. The case, Nautilus, Inc. v. Biosig Instruments, Inc., overturned the Federal Circuit’s “insolubly ambiguous” test and substituted its own “reasonable certainty” test.  The Court left intentionally unclear the precise ways in which their new test will differ from the Federal Circuit’s abrogated test, leaving it to the lower court to decide Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,